{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:27:50Z","timestamp":1776882470703,"version":"3.51.2"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["982901"],"award-info":[{"award-number":["982901"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.chemphyslip.2022.105226","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T02:08:43Z","timestamp":1657850923000},"page":"105226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A novel and easy to prepare azo-based bioreductive linker and its application in hypoxia-sensitive cationic liposomal doxorubicin: Synthesis, characterization, in vitro and in vivo studies in mice bearing C26 tumor"],"prefix":"10.1016","volume":"247","author":[{"given":"Mohammad","family":"Mashreghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Faal Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anis","family":"Askarizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helaleh","family":"Farshchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Farhoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahda Sadat","family":"Nasrollahzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahere","family":"Rezazade Bazaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Hadizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemphyslip.2022.105226_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejps.2009.07.002","article-title":"Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study","volume":"38","author":"Bai","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/mp500604r","article-title":"Relating toxicity to transfection: using sphingosine to maintain prolonged expression in vitro","volume":"12","author":"Betker","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-30517-3","article-title":"Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells","volume":"8","author":"Brownlee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3858\/emm.2009.41.12.103","article-title":"Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors","volume":"41","author":"Chen","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2217\/nnm.13.118","article-title":"Current trends in the use of liposomes for tumor targeting","volume":"8","author":"Deshpande","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0005-2736(97)00126-0","article-title":"Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells","volume":"1329","author":"Filion","year":"1997","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2007.12.017","article-title":"A review of stimuli-responsive nanocarriers for drug and gene delivery","volume":"126","author":"Ganta","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijbiomac.2019.11.190","article-title":"Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine","volume":"156","author":"Hamedinasab","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1248\/cpb.c17-00068","article-title":"Recent advances in endogenous and exogenous stimuli-responsive nanocarriers for drug delivery and therapeutics","volume":"65","author":"Hatakeyama","year":"2017","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119915","article-title":"Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells","volume":"590","author":"Joshi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0014-5793(71)80571-9","article-title":"A simple procedure for the isolation of rat liver microsomes","volume":"17","author":"Kamath","year":"1971","journal-title":"Febs Lett."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119211","article-title":"Preparation and characterization of stable nanoliposomal formulations of Curcumin with high loading efficacy: In vitro and in vivo anti-tumor study","author":"Karimi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206706","article-title":"Changes in hypoxia level of CT26 tumors during various stages of development and comparing different methods of hypoxia determination","volume":"13","author":"Kiraga","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib17","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1021\/acs.bioconjchem.6b00241","article-title":"Hypoxia responsive, tumor penetrating lipid nanoparticles for delivery of chemotherapeutics to pancreatic cancer cell spheroids","volume":"27","author":"Kulkarni","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.msec.2016.11.030","article-title":"Internal stimuli-responsive nanocarriers for drug delivery: Design strategies and applications","volume":"71","author":"Liu","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1166\/nnl.2020.3247","article-title":"Co-delivery of chloroquine and doxorubicin by hypoxia-responsive liposomes for enhanced synergistic antitumor activity in treating solid tumor","volume":"12","author":"Liu","year":"2020","journal-title":"Nanosci. Nanotechnol. Lett."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.actbio.2020.07.061","article-title":"Azo-inserted responsive hybrid liposomes for hypoxia-specific drug delivery","volume":"115","author":"Long","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib22","article-title":"Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting","author":"Maleki","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib23","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/jcp.26049","article-title":"Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis","volume":"233","author":"Mashreghi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/1061186X.2020.1870230","article-title":"Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide","volume":"29","author":"Mashreghi","year":"2021","journal-title":"J. Drug Target"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3116","article-title":"Anti\u2010epithelial cell adhesion molecule RNA aptamer\u2010conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model","author":"Mashreghi","year":"2021","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrc.2017.83","article-title":"Engineering and physical sciences in oncology: challenges and opportunities","volume":"17","author":"Mitchell","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib27","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/IJN.S165210","article-title":"Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: a systematic review","volume":"13","author":"Muhamad","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102150","article-title":"Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer","volume":"24","author":"Navashenaq","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118492","article-title":"Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study","volume":"567","author":"Nikpoor","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1201\/9780429399039-2","article-title":"Nanocarriers as an emerging platform for cancer therapy","author":"Peer","year":"2020","journal-title":"Nano-Enabled Med. Appl."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/biomedicines5020034","article-title":"The role of angiogenesis in cancer treatment","volume":"5","author":"Rajabi","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib33","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti-and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41571-021-00539-4","article-title":"Therapeutic targeting of the hypoxic tumour microenvironment","volume":"18","author":"Singleton","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6673-2-16","article-title":"Nanotechnology-based drug delivery systems","volume":"2","author":"Suri","year":"2007","journal-title":"J. Occup. Med. Toxicol."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1021\/ml5005206","article-title":"Applications of azo-based probes for imaging retinal hypoxia","volume":"6","author":"Uddin","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib40","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","article-title":"Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib41","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1002\/cber.190603903184","article-title":"Zur kenntniss der Azophenole. Berichte der Dtsch","volume":"39","author":"Willst\u00e4tter","year":"1906","journal-title":"Chem. Ges."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib42","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1021\/acs.biomac.1c00301","article-title":"Hypoxia-sensitive zwitterionic vehicle for tumor-specific drug delivery through antifouling-based stable biotransport alongside PDT-sensitized controlled release","volume":"22","author":"Yin","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib43","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/cancers11050640","article-title":"Active targeting strategies using biological ligands for nanoparticle drug delivery systems","volume":"11","author":"Yoo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.chemphyslip.2022.105226_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117646","article-title":"Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2\/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy","author":"Zamani","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib45","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s10989-021-10238-4","article-title":"Efficacy comparison of TAT peptide-functionalized PEGylated liposomal doxorubicin in C26 and B16F0 tumor mice models","volume":"27","author":"Zarazvand","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.chemphyslip.2022.105226_bib46","first-page":"3087","article-title":"Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes","volume":"6","author":"Zhao","year":"2011","journal-title":"Int. J. Nanomed."}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308422000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308422000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:34:45Z","timestamp":1757860485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009308422000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"alternative-id":["S0009308422000548"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2022.105226","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel and easy to prepare azo-based bioreductive linker and its application in hypoxia-sensitive cationic liposomal doxorubicin: Synthesis, characterization, in vitro and in vivo studies in mice bearing C26 tumor","name":"articletitle","label":"Article Title"},{"value":"Chemistry and Physics of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2022.105226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105226"}}